Fujifilm to Acquire Merck Biomanufacturing Network

The network's facilities are located in Research Triangle Park, North Carolina and Billingham, U.K.

Fujifilm will purchase all of the equity interests in two Merck subsidiaries (Diosynth RTP, LLC and MSD Biologics (U.K.) Ltd. which together own all assets of the Merck BioManufacturing Network. The network's facilities are located in Research Triangle Park, North Carolina (Diosynth RTP, LLC) and Billingham, U.K. (MSD Biologics (U.K.) Ltd.)

With this transaction, Merck/MSD becomes a key customer that will continue to benefit from the expertise and experience of the combined businesses in biologics development and manufacturing," said Willie A. Deese, executive vice president and president, Merck Manufacturing Division.

Merck/MSD Biomanufacturing Network was formed by the combination of MSD Biologics, based in Billingham, U.K. and Diosynth Biotechnology, based in Research Triangle Park, North Carolina, U.S.A. Merck BioManufacturing Network offers industry-leading cGMP contract manufacturing services for recombinant proteins, vaccines and monoclonal antibodies. The combined expertise enables customers to improve the cost-effectiveness and profitability of new therapies by providing fast-track progress into and through their clinical development program, validation and commercialization.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish